Trimebutine (Maleate)
Trimebutine (Maleate) is used as an antispasmodic.
Primary Characteristics
It belongs to Aminobenzoate.
It belongs to Alpha adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in Antispasmodic Agent pharmacological group. It is also classified under Gastrointestinal Anticholinergics/Antispasmodics .
Molecular Weight: 503.5 · Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Trimebutine Maleate.
Pharmacokinetics
Elimination: renal excretion is 70 %.
Advertisement
Indications
Trimebutine (Maleate) is primarily indicated in conditions like Abdominal pain, Constipation, Diarrhoea, Digestive disorder, Flatulence, Irritable bowel syndrome, Spasm.
Trimebutine (Maleate) is also indicated for secondary conditions like Haemorrhoids, Hemorrhoids.
Contraindications
None recorded.
Dosage
Trimebutine (Maleate)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 150 mg | 150 mg | Every 12h | PO | |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
None recorded.
Available Brands
Storage Conditions
Drug Classification
- 1.17.5 — Antispasmodics